Target intelligence / Profile preview

Canine parvovirus (CPV)

Target: CPV
Molecular classification: Virus

Overview

Canine parvovirus is a small, non-enveloped virus with a single-stranded DNA genome that primarily affects dogs. It has an icosahedral capsid composed of 60 protein subunits and causes severe gastrointestinal disease, particularly in young dogs. The virus exists in several antigenic variants and is notable for its environmental resilience and high contagiousness.

Other names: ParvoCPV-2CPV-2aCPV-2bCPV-2cCVPCCarnivore protoparvovirus 1

Mechanism of action

Not applicable (not a therapeutic target)

Biological functions

Viral replicationCell death

Disease associations

InfectionGastrointestinal disease

Safety considerations

Highly contagiousEnvironmentally resistantHigh mortality rate in untreated cases

Beyond the preview

Go deeper on Canine parvovirus (CPV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canine parvovirus (CPV).

Explore the full profile